Etoricoxib Impurity 22 | CAS 1352804-27-3 - Request Quote
Etoricoxib Impurity 22
| SZ CAT No: | SZ-E030027 |
| CAS No | 1352804-27-3 |
| Mol.F. | C5H9ClN2 : HCl |
| Mol.Wt. | 132.5 : 36.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Etoricoxib Impurity 22 is chemically (Z)-2-chloro-3-imino-N,N-dimethylprop-1-en-1-amine hydrochloride. Etoricoxib Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Etoricoxib Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Etoricoxib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1352804-27-3
Purchase 1352804-27-3
Order 1352804-27-3
Enquire 1352804-27-3
price of 1352804-27-3
1352804-27-3 Supplier
1352804-27-3 Manufacturer
1352804-27-3 Exporter
buy high quality Etoricoxib Impurity 22
Purchase Etoricoxib Impurity 22
Etoricoxib Impurity 22 suppliers
Etoricoxib Impurity 22 manufacturers
Etoricoxib Impurity 22 price
Order Etoricoxib Impurity 22
Enquire Etoricoxib Impurity 22
Etoricoxib Impurity 22 cost
Etoricoxib Impurity 22 Supplier
Etoricoxib Impurity 22 Distributor
Etoricoxib Impurity 22 for Method Validation
Etoricoxib Reference Standard
Etoricoxib Impurity 22 for ANDA Filing
Etoricoxib Impurity 22 for Forced Degradation Studies
Etoricoxib Impurity 22 Identification Standards
Etoricoxib Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.